New committee will trial novel approaches to drug reviews and expand support for decision-makers to unleash the value of drugs across their lifespan.
CADTH, Canada’s drug and health technology agency, announces the creation and inaugural membership of a new Formulary Management Expert Committee as…
Today, CADTH is communicating a series of improvements that will further our ambition to innovate in the field of health technology assessment (HTA), adapt to changing regulatory and reimbursement environments, and improve the pathway that brings effective drugs to patients across Canada.
During…
CADTH, Health Canada, and the Institut national d’excellence en santé et en services sociaux (INESSS) are seeking to advance the use of real-world evidence in regulatory and health technology assessment decision-making
A final guidance document published today provides important direction on…
CADTH presents its top awards for career achievement to Dr. Brian O’Rourke and Dr. Kednapa Thavorn during the 2023 CADTH Symposium.
Ottawa, May 16, 2023 — Today, CADTH, Canada’s drug and health technology agency, announced the recipients of its 2023 Recognition Awards. These prizes honour…
During a 1-year learning period, CADTH expanded its Scientific Advice program to include advice on real-world evidence (RWE), allowing applications after lockdown of protocols for pivotal trials. Based on the positive experience and considerable interest from industry, CADTH is formalizing this…
The position statement is a step toward greater transparency of unpublished data and a tangible outcome resulting from cooperation among global health technology assessment bodies
CADTH, Canada’s drug and health technology agency, in collaboration with the Institute for Clinical and Economic Review…
CADTH is inviting stakeholder feedback on a proposal to introduce time-limited reimbursement recommendations. These are recommendations that would be issued in favour of reimbursement in a manner that is time-limited and contingent upon a future reassessment of additional evidence that addresses…
Registration Is Now Open!
Join the global health technology assessment (HTA) community for the 2023 CADTH Symposium.
This year’s theme is Shaping Future-Ready Health Systems. The CADTH Symposium is a 3-day hybrid event that will be held on May 16, 17, and 18, 2023. There are both in-person and…
CADTH is seeking nominations for its Board of Directors, and expert and advisory committees. We are currently accepting applications from individuals with significant expertise in the Canadian health care system who are interested in helping support health care decision-makers in making informed…
Amid the growth in precision medicine, a new CADTH report unpacks the hype from hope about these technologies and highlights the issues that could influence their adoption
Tests that could alter traditional pathways for cancer care. Tools that offer access to genetic test results and ways to engage…
Three new reports from CADTH are bringing health care decision-makers valuable new insight on post–COVID-19 condition, also known as long COVID.
The reports include an environmental scan of specialized clinics and professional resources in Canada, an update of the evidence landscape for the…
CADTH is pleased to announce recent organizational changes that are strengthening the execution of the organization’s strategic ambitions and advancing life cycle health technology management.
As part of these changes, CADTH has merged its Pharmaceutical Reviews program and Medical Devices and…